Records containing: Hodgkin's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-07-21Hodgkin's Lymphoma: Prognostic Value of the Kinetic of Decrease of 5 Cytokines Concentration During Treatment
-
CLINICAL_TRIALS study record update · 2017-07-02Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
-
CLINICAL_TRIALS study record update · 2017-06-14Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2017-02-14Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2017-02-10A Phase II Trial on Allogeneic Cytokine-induced Killer Cell Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-01-26Allogeneic Hematopoietic Cell Transplantation of Positively Selected CD34+ Cells and Defined Inoculum of T Cells From Related Haploidentical Donors for Older Patients With Indolent Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2017-01-19A Phase II Study of Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma.
-
CLINICAL_TRIALS study record update · 2016-10-04A Phase I-II Study to Determine the Safety, Pharmacokinetics and Potential Efficacy of Intravenous Administration of SB-743921 on Days 1 and 15 of a 28-Day Dosing Schedule in Patients With Non-Hodgkin Lymphoma and Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2016-09-12A Phase I Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-08-19A Phase 1 Dose Escalation Study of Infusion of ex Vivo cd3/cd28 Costimulated Umbilical Cord Blood-derived t Cells in Adults Undergoing Transplantation for Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-07-25Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis
-
CLINICAL_TRIALS study record update · 2016-06-23A Dose Escalation Study of NK-92 Cell Infusions in Patients With Hematological Malignancies in Relapse After Autologous Stem Cell Transplantation.
-
CLINICAL_TRIALS study record update · 2016-05-05Registry Study of T Cell Depleted Allogeneic Non-Myeloablative Stem Cell Transplant Recipients
-
CLINICAL_TRIALS study record update · 2016-04-27A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2016-02-26Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent GVHD After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
-
CLINICAL_TRIALS study record update · 2016-02-01Pilot Trial of Rituximab (Rituxan) for the Prevention of EBV-LPD Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT
-
CLINICAL_TRIALS study record update · 2016-01-14A Phase II Trial of Total Body Irradiation-Based Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-01-08A Multicentre Phase II Study of Risk-adjusted Outpatient-based Salvage Therapy for Patients With Relapsed and Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2016-01-08A Pilot Study of Outpatient Vinorelbine and Gemcitabine With Filgrastim Support for Patients With Relapsed or Refractory Lymphoma.
-
CLINICAL_TRIALS study record update · 2015-12-28Spectroscopy With Surface Coils and Decoupling
-
CLINICAL_TRIALS study record update · 2015-12-23A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
-
CLINICAL_TRIALS study record update · 2015-12-07ClinicalTrials.gov study NCT00001575
-
CLINICAL_TRIALS study record update · 2015-12-03A Phase I Study of the Safety and Pharmacokinetics of Escalating Intravenous Doses of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2015-11-24A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2015-10-12An Open-label, Randomized, Multicenter, Phase II Study of MDX-060 in Combination With Gemcitabine, MDX060 in Combination With Dexamethasone, and Gemcitabine Monotherapy in Patients With Relapsed or Refractory Hodgkin's Disease